Susan Mahony, SVP & President, Lilly Oncology at LILLY ELI & CO (LLY), sold 45,088 shares at $80.08 ($3.6M) on 2018-04-16, disclosed to the SEC on 2018-04-17.
Open-market sale of $3.6M LLY by SVP & President, Lilly Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.14 | 5,165 | $414K | 11.5% |
| 2 | $80.14 | 5,165 | $414K | 11.5% |
| 3 | $80.08 | 17,379 | $1.4M | 38.5% |
| 4 | $80.08 | 17,379 | $1.4M | 38.5% |
| Total | $80.09 avg | 45,088 | $3.6M | 100% |
| Filing → |
| LLY | SELL | 2016-12-19 | $2.9M | — | Filing → |
| LLY | SELL | 2015-07-29 | $2.1M | — | Filing → |
| LLY | SELL | 2014-07-30 | $131K | — | Filing → |